Medicago vaccine approved for people aged 18 to 64.
Health Canada has authorized the use of the first made-in Canada COVID-19 vaccine.
Medicago's two-dose plant-based vaccine has been approved for anyone aged 18 to 64.
Health Canada says the vaccine's effectiveness and safety for anyone outside of that age bracket has not been determined yet.
The dosing schedule is 21 days apart, and clinical trials suggest the vaccine was 71 percent effective in protecting against COVID-19 one week after the second dose.
The Quebec company submitted data to Health Canada in December.
City Encouraged to Go After Funding
Cost of Renewing Vows Could Rise
GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash
NRP Officers Praised by Management
945 Supportive Housing Units Approved
Niagara Talks Canadian Defense
Niagara Falls Expecting More Evacuees